Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
Abstract Background Comprehensive molecular subtyping of diffuse large B‐cell lymphoma (DLBCL) through genetic profiling has broadened our understanding of DLBCL biology. In this study, we investigated whether DLBCL, not otherwise specified (NOS) shows differences in mutational patterns depending on...
Main Authors: | Hyun‐Hee Koh, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Junhun Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6533 |
Similar Items
-
Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma
by: Shih-Feng Cho, et al.
Published: (2024-03-01) -
Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma
by: Yunjoo Cho, et al.
Published: (2024-01-01) -
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
by: Hyunjee Lee, et al.
Published: (2023-08-01) -
Burkitt's lymphoma presenting as ovarian mass and ileocecal intussusception in an adult
by: Chung-Hsiung Liu, et al.
Published: (2018-01-01) -
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
by: Sun Young Jeong, et al.
Published: (2023-01-01)